申请人:Mitsubishi Kasei Corporation
公开号:US05202351A1
公开(公告)日:1993-04-13
A novel 1-phenylalkyl-3-phenylurea derivative represented by the following formula (I): ##STR1## wherein R.sup.1 and R.sup.5 represent independently hydrogen, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.5 alkoxyl or halo; R.sup.2 represents hydrogen or C.sub.1 -C.sub.15 alkyl; R.sup.3 represents C.sub.1 -C.sub.15 alkyl or R.sup.3 represents together with R.sup.2 C.sub.2 -C.sub.9 alkylene; R.sup.4 and R.sup.5 represent independently C.sub.1 -C.sub.5 alkyl, C.sub.1 -C.sub.5 alkoxyl or halo; X represents oxygen or sulfur; Y represents --O--(CH.sub.2).sub.l --O-- wherein l is an integer of 1 to 3 or --(CH.sub.2).sub.p -- wherein p is an integer of 3 to 5; m is 0 or an integer of 1 to 5; and n is 0 or an integer of 1 to 3, is provided. The 1-phenylalkyl-3-phenylurea derivative (I) have the action of reducing cholesterol in blood by ACAT inhibition, and therefore, useful for treating hyperlipemia and atherosclerosis.
一种由以下公式(I)表示的新型1-苯基烷基-3-苯基脲衍生物:其中R.sup.1和R.sup.5分别独立表示氢、C.sub.1 -C.sub.6烷基、C.sub.1 -C.sub.5烷氧基或卤素;R.sup.2表示氢或C.sub.1 -C.sub.15烷基;R.sup.3表示C.sub.1 -C.sub.15烷基或R.sup.3与R.sup.2一起表示C.sub.2 -C.sub.9亚烷基;R.sup.4和R.sup.5独立表示C.sub.1 -C.sub.5烷基、C.sub.1 -C.sub.5烷氧基或卤素;X表示氧或硫;Y表示--O--(CH.sub.2).sub.l --O--其中l为1至3的整数或--(CH.sub.2).sub.p --其中p为3至5的整数;m为0或1至5的整数;n为0或1至3的整数。提供了1-苯基烷基-3-苯基脲衍生物(I),具有通过ACAT抑制作用降低血液中胆固醇的作用,因此,对治疗高脂血症和动脉粥样硬化有用。